About 1 in 15 people with celiac disease develops a blistering, intensely itchy skin rash that is a form of celiac disease itself — not a separate condition, not an allergy, but the same immune reaction playing out on the skin instead of the gut. New research covered by Celiac.com puts a concrete population-level number on how common this condition — called dermatitis herpetiformis (DH) — is among people already living with celiac disease.
That number matters because DH is one of celiac’s most chronically misdiagnosed presentations. Patients collect diagnoses of eczema, psoriasis, or contact dermatitis for years — sometimes more than a decade — while continuing to eat gluten and accumulating intestinal damage. The rash clears on a strict gluten-free diet, just as intestinal celiac does. But only if someone recognizes it first.
What This Means for You
DH does not look like what most people picture when they hear “celiac disease.” There is no nausea, no bloating, no diarrhea. There is a rash — typically on the elbows, knees, buttocks, scalp, or back — that itches with an intensity patients consistently describe as unbearable. It blisters, crusts over, and returns. Because there is often no obvious gut involvement, neither patients nor their doctors think to test for celiac. A dermatologist sees a rash, prescribes a steroid cream, it helps a little, the rash comes back. That cycle can repeat for years.
As a parent navigating celiac for my son, I’m mostly focused on the intestinal side of this disease — but this study is a useful reminder that celiac doesn’t always announce itself through digestion. For celiac families, the practical takeaway is straightforward: if someone with celiac develops a chronic, treatment-resistant skin rash, DH belongs on the list of possibilities regardless of how well the gut seems to be doing.
This study’s 1-in-15 prevalence figure also gives dermatologists and primary care physicians clearer grounds for thinking about celiac when a patient walks in with an unexplained blistering rash. A condition affecting roughly 6 to 7 percent of celiac patients is not rare — it’s a significant presentation that deserves to be on every clinician’s radar.
DH can emerge at any age, including in children and adolescents. If a celiac patient develops an unexplained rash, raise DH specifically with their gastroenterologist or a dermatologist experienced with the condition. The diagnostic path is different from standard celiac testing, and a general referral may not be enough.
Key Takeaways
- About 1 in 15 people with celiac disease — roughly 6–7% — has dermatitis herpetiformis, a blistering skin rash triggered by gluten exposure.
- DH often presents without gut symptoms, so celiac is easy to miss as the cause.
- The rash typically appears on elbows, knees, buttocks, scalp, and back.
- A strict gluten-free diet is the primary treatment — the same treatment that heals intestinal celiac, though the rash takes longer to clear.
- Standard celiac blood tests are unreliable for DH; diagnosis requires a specific skin biopsy taken from skin adjacent to the rash.
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
Why the Skin Is a Celiac Target
Celiac disease is an autoimmune condition — the immune system attacks the body’s own tissue in response to gluten, the protein found in wheat, barley, and rye. In intestinal celiac, the immune attack damages the lining of the small intestine. In DH, the attack lands on the skin.
The mechanism linking them: when someone with DH eats gluten, the immune system generates IgA antibodies (proteins the immune system produces to flag and neutralize threats). Instead of clearing normally, these antibodies deposit in structures called dermal papillae — tiny finger-like projections in the uppermost layer of the skin. That accumulation drives inflammation, which produces the characteristic blisters. This is why DH is formally classified as a manifestation of celiac disease rather than a separate diagnosis. The trigger is identical. The treatment is identical. What differs is where the immune reaction concentrates.
How Diagnosis Actually Works
The standard celiac blood test — the tTG-IgA assay (tissue transglutaminase IgA antibody, which measures immune reactivity to gluten) — can be elevated in DH patients, but it isn’t reliable enough on its own to confirm the diagnosis. The definitive test is a skin biopsy taken from uninflamed skin next to the rash, not from the rash itself. Biopsying the blistered lesion typically yields inconclusive results because the tissue is already damaged. The biopsy sample is then examined under direct immunofluorescence — a technique using fluorescent dyes to make IgA deposits visible under a microscope. Visible deposits confirm DH.
Many dermatologists unfamiliar with DH biopsy the lesion and miss the diagnosis. Patients or caregivers who suspect DH should ask their dermatologist explicitly to biopsy from normal-appearing skin adjacent to the rash and to test for IgA deposits specifically.
What the 1-in-15 Figure Adds to the Research
Earlier prevalence estimates for DH among celiac patients varied considerably. Clinic-based studies — which skew toward patients who sought specialist care — sometimes reported rates as high as 15 to 25 percent. Population-level studies, which capture a broader and more representative group, tend to produce lower figures. A population-level estimate near 6 to 7 percent is meaningful precisely because it reflects what is happening across the full celiac population, not just at specialty centers.
That distinction matters for clinical guidelines. When the prevalence figure comes from a population study rather than a specialist clinic, it carries more weight in shaping how often dermatologists and primary care physicians should be screening for celiac when they see a chronic, blistering rash.
Treatment: Diet First, Medication to Bridge the Gap
A strict gluten-free diet is the foundation of DH treatment. IgA deposits in the skin clear slowly — full resolution of the rash can take 18 to 24 months of rigorous dietary adherence, which is longer than the intestinal healing timeline in typical celiac disease. During that clearing period, many patients are prescribed dapsone, an anti-inflammatory drug that reduces the immune-driven skin inflammation and controls the rash while the diet takes effect. Dapsone manages the symptom; the gluten-free diet addresses the cause.
For DH patients, cross-contact — gluten traces from shared preparation surfaces, utensils, or mislabeled products — is particularly consequential. Even small gluten exposures can re-trigger IgA deposition and restart the rash cycle.
The broader health picture for DH patients warrants attention beyond the skin. We covered a matched cohort study on mortality, cardiovascular disease, and cancer in celiac disease and dermatitis herpetiformis that found DH carries its own distinct long-term risk profile — and we looked at neurological comorbidities in a DH cross-sectional study that showed the condition’s reach extends well beyond the skin. Both findings reinforce that DH is not a milder or peripheral form of celiac disease. It deserves the same level of medical follow-through.
If you are managing celiac in your family and a persistent, unexplained skin rash enters the picture, bring this prevalence data to the next medical appointment. One in 15 is not a long shot — it is common enough to test for.
Related Coverage
- Cross-sectional Study of Dermatitis Herpetiformis with Focus on Neurological Comorbidities
- Mortality, cardiovascular disease, and cancer in coeliac disease and dermatitis herpetiformis: a matched cohort study
References
- Celiac.com. “Study Finds Dermatitis Herpetiformis Affects About 1 in 15 People With Celiac Disease.” Published August 17, 2026. Source